We Pharma, INC.
UEI EWAMVJSFNK29 · NC · SAM.gov record ↗
$972K
FY2025 obligations
7
Contract awards
Jun 29, 2018
First action
Sep 16, 2025
Latest action
Obligations by agency
- Department Of Health And Human Services$972K
Obligations by NAICS
Monthly obligations
Nov 24
Mar 25
May 25
Jun 25
Jul 25
Sep 25
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75F40125F19004 ↗ | TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF PHARMACEUTICAL QUALITY RESEARCH (OPQR). | Food And Drug Administration | 424210 | $607K | Jul 28, 2025 | Aug 6, 2026 |
| 75F40125F19011 ↗ | PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES. | Food And Drug Administration | 325412 | $300K | Sep 16, 2025 | Sep 16, 2026 |
| 75F40125F19010 ↗ | PHARMACEUTICAL DRUG PRODUCTS | Food And Drug Administration | 325412 | $75K | May 14, 2025 | Nov 13, 2026 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75F40125F19004 ↗ | TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF PHARMACEUTICAL QUALITY RESEARCH (OPQR). | Food And Drug Administration | 424210 | $607K | Jul 28, 2025 | Aug 6, 2026 |
| 75F40125F19011 ↗ | PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES. | Food And Drug Administration | 325412 | $300K | Sep 16, 2025 | Sep 16, 2026 |
| 75F40125F19010 ↗ | PHARMACEUTICAL DRUG PRODUCTS | Food And Drug Administration | 325412 | $75K | May 14, 2025 | Nov 13, 2026 |
| 75F40124F19009 ↗ | MOD P00002 - TO CORRECT PRIOR FISCAL YEAR FUNDING FROM EACH TO DOLLARS. | Food And Drug Administration | 325412 | $0 | Apr 25, 2024 | Aug 6, 2025 |
| 75F40121D00018 ↗ | THE CONTRACTOR SHALL PROVIDE THE FDA WITH THE FOLLOWING: I. PRODUCTS LISTED IN ATTACHMENT 1 (PHARMACEUTICAL PRICING LIST), IN RESPONSE TO GOVERNMENT ORDERS. AT A MINIMUM, THIS TABLE WILL BE UPDATED ONCE A YEAR. II. SUPPLY EMERGENCY OVERNIGHT DELI | Food And Drug Administration | 424210 | $0 | Jun 25, 2021 | — |
| 75F40118P20106 ↗ | PHARMACEUTICAL PRODUCTS | Food And Drug Administration | 325412 | $-85 | Jun 29, 2018 | Jul 15, 2020 |
| 75F40123F19008 ↗ | PHARMACEUTICAL DRUG PRODUCT ORDERS. THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT. | Food And Drug Administration | 325412 | $-10K | Jul 31, 2023 | Aug 6, 2024 |